Announcements and Notices - [Connected Transaction]

Mabpharm Limitied manufactures medical products. The Company produces cancer treatment drugs, immune diseases drugs, biosimilar drugs, and other products. Mabpharm markets its products throughout China.

Connected Transactions Termination Of 2021 Tenancy Agreement

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024 Interim Report

Announcements and Notices - [Interim Results]

Interim Results Announcement For The Six Months Ended June 30, 2024

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [List of Directors and their Role and Function]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MabPharm (2181 HK)

Connected Transactions Termination Of 2021 Tenancy Agreement

2024 Interim Report

Interim Results Announcement For The Six Months Ended June 30, 2024

Date Of Board Meeting

List Of Directors And Their Roles And Functions

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)